Navigation Links
Citalopram, a Boon in Treating Depressed Heart Patients

Canadian researchers have come out with findings from a study that indicates the superiority of selective serotonin reuptake inhibitors (SSRIs) like celexa in combating// depression.

Dr. Fran?ois Lespérance, a psychiatrist at the University of Montreal and his colleagues published their findings in this week’s edition of the Journal of the American Medical Association.

The drug celexa, which goes by the generic name citalopram, is prescribed for patients suffering from major depression that lasts more than two weeks.

Depression is commonly associated with coronary heart disease or CAD. Around 17 to 27 percent of CAD diagnosed patients are found to suffer from depression.

The study involved 284 CAD patients and lasted a period of 12 weeks.

They were asked to undergo three modes of treatment: half to take clinical management with or without psychotherapy sessions and the other half to take the drug celexa or a placebo.

Clinical management included doctor visits to discuss depression and medication use, provide reassurance, and inquire about patients' symptoms. Psychotherapy took place immediately after the clinical management sessions, and dealt with problems such as interpersonal conflicts, life transitions, grief and loss, and social isolation.

The results observed showed that there was reduction in depression symptoms by half as compared with that of the control patients, while surprisingly psychotherapy sessions did not show any reduction in depression.

Standardized depression scores were 67 percent more likely to drop by half on citalopram than placebo, and the chance of depression remitting was almost doubled.

Says Dr. Lesperance, "Citalopram or sertraline, as previously shown in [a different trial], plus clinical management should be considered for the initial acute-phase treatment for major depression in patients with coronary artery disease.”

Physicians Alexan der Glassman and J. Thomas Bigger of the New York State Psychiatric Institute who opine that the study provides further evidence that SSRIs combat depression in heart disease victims support the authors’ findings.
NN
'"/>




Related medicine news :

1. Treating eye pain eases migraine
2. Treating wounds without stitches
3. Treating varicose veins
4. Treating acne with laser
5. Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections
6. Treating Stroke Patients in Rural Areas
7. Free Tissue Transfer Effective in Treating Massive Skin Cancers
8. Treating Blocked Arteries In The Lower Limbs
9. Zinc Supplements Found To Be Effective In Treating Children With ADHD
10. Hormone Leptin Found To Be Effective In Treating Women With Infertility Problems
11. Treating Depression In Children Could Lead To Poor Bone Development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... AvePoint , the Microsoft Cloud expert, is ... Richmond, Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating ... Ralph S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in 2001, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, ... public to take the Diabetes Risk Test to find out if they are at ... World Airports will light up the evening sky by programming the LAX pylons the ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, property values, ... leader in the real estate valuation industry for more than 40 years. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... ... thyroid pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched on ... answering common questions regarding thyroid function. , Dr. Izabella Wentz is a ...
(Date:3/28/2017)... ... 28, 2017 , ... Medforce Technologies, Inc., a leading provider ... has joined the National Association for Home Care and Hospice (NAHC), the largest ... dying Americans of all ages and the caregiver who provide them with in-home ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 On March 28, the U.S. ... adult patients with relapsing forms of multiple sclerosis (MS) ... first drug approved by the FDA for PPMS. Ocrevus ... professional.  "Multiple sclerosis can have a ... Dunn , M.D., director of the Division of Neurology ...
(Date:3/29/2017)... March 29, 2017 FinancialBuzz.com News Commentary  ... The U.S. could see ... a new report published by New Frontier Data, the legal cannabis ... pace of cannabis legalization in the United States ... considered to be a major factor that drives growth in this ...
(Date:3/28/2017)... YORK , March 28, 2017 "Chemotherapy Induced Neutropenia ... overview of the disease and global market trends of the Chemotherapy ... States , Europe ( France ... , Spain , UK) and Japan ... (RoE) and rest of the world (RoW). The ...
Breaking Medicine Technology: